CardiaTec is at the forefront of drug development for cardiovascular diseases. Through sequencing and AI, they are generating the largest multiomics dataset surrounding human hearts to uncover novel therapeutics.
Lucy Ahern
November 20, 2024
Cultivated or cultured meat is an exciting technology that provides an alternative to traditional farmed, animal meat. It has various advantages in environmental impact, animal welfare, and more. Meatly is a start-up producing cultivated, lab-grown meat and what sets them apart is that they specialise in producing pet food.
Sandeep Mangrati
November 20, 2024
Kadence Bio (formerly Kanna Health) is a clinical-stage drug development company pioneering new treatments for sexual health. Their lead asset, KH-001, is being developed as the first FDA-approved treatment for premature ejaculation. The company recently completed a Phase I clinical trial and is planning to initiate Phase II trials next year.
Laura Castillo De Franca
October 14, 2024
A dementia diagnosis can leave people feeling adrift and alone. They’re often left with mounds of questions but very limited access to personalised information or specialists. We had the opportunity to speak to Anna Muñoz Farré, founder and CEO of Punto Health, about how they are starting a dementia care revolution.
Megan Thomas
July 31, 2024
Founded in 2020 by neuroscientist Tim Routledge and marketing leader Tim Wade, Biostress Lab Ltd set sail from Wakefield, England, with a mission to revolutionise workplace well-being.
Omar Ajaz
July 30, 2024
BoobyBiome, a start-up innovating the realm of infant health, is spearheading efforts to redefine neonatal care through a deep understanding of the gut microbiome. Founded by Lydia, Sioned, and Tara, they are dedicated to leveraging cutting-edge science to optimise infant health outcomes, particularly focusing on premature infants.
Joanna Myslinska
July 11, 2024
Sign up for our monthly newsletter of upcoming events, recently published insights and SEC updates.